
COSENTYX® (secukinumab) | Home
Learn more about COSENTYX® (secukinumab), a treatment option for PsO, HS, PsA, AS, nr-axSpA, pediatric PsO, and pediatric JIA. See full prescribing and safety information.
Psoriatic Arthritis Treatment | COSENTYX® (secukinumab)
Learn about COSENTYX, a biologic treatment for active psoriatic arthritis (PsA). See full prescribing & safety information.
Cosentyx Assistance Program | COSENTYX® (secukinumab)
Program provides COSENTYX for free to eligible patients for up to two years, or until they receive insurance coverage approval, whichever occurs earlier. A valid prescription consistent with FDA …
Plaque Psoriasis Treatment | COSENTYX® (secukinumab)
Discover COSENTYX, an injectable prescription medication for the treatment of moderate to severe plaque psoriasis (PsO). See full prescribing and safety info.
Safety And Side Effects | COSENTYX® (secukinumab)
Access additional safety and side effects information for COSENTYX® (secukinumab). Discover facts and commonly asked questions. See full prescribing and safety information.
How Does COSENTYX Work? | PsO | COSENTYX® (secukinumab)
Learn more about how COSENTYX works for moderate to severe Plaque Psoriasis (PsO). See full prescribing and safety info.
Injection Resources | COSENTYX® (secukinumab)
Access resources and videos about how to inject COSENTYX® (secukinumab). Learn about available injection devices and dosages. See full prescribing & safety information.
Plaque Psoriasis Dosing | COSENTYX® (secukinumab)
Learn more about the once-monthly dosing of COSENTYX to treat multiple symptoms of plaque psoriasis (PsO). See full prescribing & safety information.
Hidradenitis Suppurativa | COSENTYX® (secukinumab)
Access information about Cosentyx® (secukinuamb), as a treatment option for Hidradenitis Suppurativa (HS). See full Prescribing & Safety Information.
How Does Cosentyx Work | COSENTYX® (secukinumab)
How does COSENTYX work? COSENTYX is the first FDA-approved biologic of its kind. COSENTYX can help treat ankylosing spondylitis (AS) by targeting a molecule called IL-17A, one of the …